June Sherie Almenoff, COO and Chief Medical Officer at INNOVATE BIOPHARMACEUTICALS, INC. (INNT), bought 1,400 shares at $4.99 ($7K) on 2018-08-24, disclosed to the SEC on 2018-08-28.
Open-market purchase of $7k INNT by COO and Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.85 | 100 | $485 | 7.0% |
| 2 | $4.85 | 500 | $2K | 35.2% |
| 3 | $4.99 | 400 | $2K | 29.0% |
| 4 | $4.90 | 47 | $230 | 3.3% |
| 5 | $4.94 | 100 | $494 | 7.2% |
| 6 | $4.96 | 253 |
| $1K |
| 18.2% |
| Total | $4.92 avg | 1,400 | $7K | 100% |
| Filing → |
| BCLI | BUY | 2019-01-08 | $5K | — | Filing → |
| OHRP | BUY | 2015-02-10 | $41K | — | Filing → |
| OHRP | BUY | 2014-06-30 | $27K | — | Filing → |